Peng SR - Search Results

1

Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer.

Xiong Z, Zhuang RL, Yu SL, Xie ZX, Peng SR, Li ZA, Li BH, Xie JJ, Li YN, Li KW, Huang H. Xiong Z, et al. Among authors: peng sr. J Adv Res. 2024 Dec 6:S2090-1232(24)00559-9. doi: 10.1016/j.jare.2024.12.003. Online ahead of print. J Adv Res. 2024. PMID: 39647634 Free article.

2

Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis.

Xiong Z, Yu SL, Xie ZX, Zhuang RL, Peng SR, Wang Q, Gao Z, Li BH, Xie JJ, Huang H, Li KW. Xiong Z, et al. Among authors: peng sr. iScience. 2024 Apr 4;27(5):109674. doi: 10.1016/j.isci.2024.109674. eCollection 2024 May 17. iScience. 2024. PMID: 38646169 Free PMC article.

3

Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methods.

Li K, Li Z, Tao Y, Wang Q, Lai Y, Wu W, Peng S, Guo Z, Huang H. Li K, et al. Future Med Chem. 2019 Dec;11(24):3125-3137. doi: 10.4155/fmc-2019-0223. Future Med Chem. 2019. PMID: 31838901

4

SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion.

Li Z, Tao Y, Gao Z, Peng S, Lai Y, Li K, Chen X, Huang H. Li Z, et al. J Transl Med. 2023 May 5;21(1):303. doi: 10.1186/s12967-023-04146-y. J Transl Med. 2023. PMID: 37147713 Free PMC article.

5

Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression.

Xiong Z, Tong T, Xie Z, Yu S, Zhuang R, Jia Q, Peng S, Li B, Xie J, Li K, Wu J, Huang H. Xiong Z, et al. Biomater Sci. 2024 Jan 30;12(3):650-659. doi: 10.1039/d3bm01735d. Biomater Sci. 2024. PMID: 38168678

6

Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy.

Yu S, Zhang R, Xie Z, Xiong Z, Peng S, Li B, Zhuang R, Wu J, Huang H. Yu S, et al. ACS Biomater Sci Eng. 2024 Jul 8;10(7):4336-4346. doi: 10.1021/acsbiomaterials.4c00345. Epub 2024 Jun 8. ACS Biomater Sci Eng. 2024. PMID: 38850557

7

Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer.

Li B, Cheng B, Huang H, Huang S, Yu S, Li Z, Peng S, Du T, Xie R, Huang H. Li B, et al. Int J Biol Sci. 2024 Sep 3;20(12):4635-4653. doi: 10.7150/ijbs.101039. eCollection 2024. Int J Biol Sci. 2024. PMID: 39309439 Free PMC article.

8

Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study.

Chen P, Wang Y, Xiong Z, Luo T, Lai Y, Zhong H, Peng S, Zhuang R, Li K, Huang H. Chen P, et al. Cancer Pathog Ther. 2024 Mar 29;2(4):292-298. doi: 10.1016/j.cpt.2024.03.002. eCollection 2024 Oct. Cancer Pathog Ther. 2024. PMID: 39371096 Free PMC article.

9

HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma.

Zhou QH, Li KW, Chen X, He HX, Peng SM, Peng SR, Wang Q, Li ZA, Tao YR, Cai WL, Liu RY, Huang H. Zhou QH, et al. Among authors: peng sr. J Immunother Cancer. 2020 Jan;8(1):e000157. doi: 10.1136/jitc-2019-000157. J Immunother Cancer. 2020. PMID: 31959726 Free PMC article.

10

Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway.

Li K, Peng S, Li Z, Lai Y, Wang Q, Tao Y, Wu W, Zhou Q, Gao Z, Chen J, Li H, Cai W, Guo Z, Huang H. Li K, et al. Aging (Albany NY). 2020 May 27;12(10):9948-9958. doi: 10.18632/aging.103260. Epub 2020 May 27. Aging (Albany NY). 2020. PMID: 32459662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters